Claret Asset Management’s Elanco Animal Health ELAN Stock Holding History

Claret Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Sell	9,119 -6,898	-43%	-$159K	0.02%	411
2026 Q1	$383K	Buy	16,017 +3	+0%	+$73	0.05%	144
2025 Q4	$362K	Sell	16,014 -38	-0.2%	-$827	0.04%	144
2025 Q3	$323K	Sell	16,052 -229	-1%	-$3.84K	0.04%	145
2025 Q2	$232K	Buy	+16,281	New	+$190K	0.03%	342
2025 Q1	–	Sell	-10,929	Closed	-$124K	–	299
2024 Q4	$132K	Buy	10,929 +76	+0.7%	+$994	0.02%	303
2024 Q3	$159K	Buy	10,853 +57	+0.5%	+$794	0.03%	328
2024 Q2	$156K	Buy	+10,796	New	+$173K	0.03%	246

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Claret Asset Management's ELAN Position: Q2 2026 in Review

Claret Asset Management reduced its Elanco Animal Health (ELAN) stake by 43% in Q2 2026, selling an estimated $159K and leaving 9,119 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #411.

Claret Asset Management first reported a position in ELAN in Q2 2024 and has held it in 8 quarters since. The position peaked at $383K in Q1 2026. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Claret Asset Management held 9,119 shares of Elanco Animal Health worth $224K as of Q2 2026.
Claret Asset Management sold 6,898 Elanco Animal Health shares in Q2 2026, an estimated $159K.
Elanco Animal Health made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #411 holding.
Claret Asset Management first reported a position in Elanco Animal Health in Q2 2024 and has held it in 8 quarters since.
Claret Asset Management's Elanco Animal Health position peaked at $383K in Q1 2026.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.